BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 18509533)

  • 1. Iron(III)-salophene: an organometallic compound with selective cytotoxic and anti-proliferative properties in platinum-resistant ovarian cancer cells.
    Lange TS; Kim KK; Singh RK; Strongin RM; McCourt CK; Brard L
    PLoS One; 2008 May; 3(5):e2303. PubMed ID: 18509533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Organometallic iron(III)-salophene exerts cytotoxic properties in neuroblastoma cells via MAPK activation and ROS generation.
    Kim KK; Singh RK; Strongin RM; Moore RG; Brard L; Lange TS
    PLoS One; 2011 Apr; 6(4):e19049. PubMed ID: 21559503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel indole ethyl isothiocyanate (7Me-IEITC) with anti-proliferative and pro-apoptotic effects on platinum-resistant human ovarian cancer cells.
    Singh RK; Lange TS; Kim KK; Shaw SK; Brard L
    Gynecol Oncol; 2008 May; 109(2):240-9. PubMed ID: 18329084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic and chemotherapeutic properties of iron (III)-salophene in an ovarian cancer animal model.
    Lange TS; McCourt C; Singh RK; Kim KK; Singh AP; Luisi BS; Alptürk O; Strongin RM; Brard L
    Drug Des Devel Ther; 2009 Sep; 3():17-26. PubMed ID: 19920918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells.
    Singh RK; Lange TS; Kim KK; Brard L
    Invest New Drugs; 2011 Feb; 29(1):63-72. PubMed ID: 19865799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells.
    Kim KK; Lange TS; Singh RK; Brard L
    BMC Cancer; 2010 Feb; 10():72. PubMed ID: 20184758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of a vitamin D(3) derivative (B3CD) with postulated anti-cancer activity in an ovarian cancer animal model.
    Lange TS; Stuckey AR; Robison K; Kim KK; Singh RK; Raker CA; Brard L
    Invest New Drugs; 2010 Oct; 28(5):543-53. PubMed ID: 19582372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diammine dicarboxylic acid platinum enhances cytotoxicity in platinum-resistant ovarian cancer cells through induction of apoptosis and S-phase cell arrest.
    Zheng H; Hu W; Yu D; Shen DY; Fu S; Kavanagh JJ; Wei IC; Yang DJ
    Pharm Res; 2008 Oct; 25(10):2272-82. PubMed ID: 18509599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene-specific repair of Pt/DNA lesions and induction of apoptosis by the oral platinum drug JM216 in three human ovarian carcinoma cell lines sensitive and resistant to cisplatin.
    O'Neill CF; Koberle B; Masters JR; Kelland LR
    Br J Cancer; 1999 Dec; 81(8):1294-303. PubMed ID: 10604725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
    Kassab AE; Hassan RA
    Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High effectiveness of platinum(IV) complex with adamantylamine in overcoming resistance to cisplatin and suppressing proliferation of ovarian cancer cells in vitro.
    Kozubík A; Horváth V; Svihálková-Sindlerová L; Soucek K; Hofmanová J; Sova P; Kroutil A; Zák F; Mistr A; Turánek J
    Biochem Pharmacol; 2005 Feb; 69(3):373-83. PubMed ID: 15652229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Fe(III)(salophene)Cl], a potent iron salophene complex overcomes multiple drug resistance in lymphoma and leukemia cells.
    Lee SY; Hille A; Kitanovic I; Jesse P; Henze G; Wölfl S; Gust R; Prokop A
    Leuk Res; 2011 Mar; 35(3):387-93. PubMed ID: 21131047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-Caryophyllene Suppresses Ovarian Cancer Proliferation by Inducing Cell Cycle Arrest and Apoptosis.
    Arul S; Rajagopalan H; Ravi J; Dayalan H
    Anticancer Agents Med Chem; 2020; 20(13):1530-1537. PubMed ID: 32106806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-proliferative activity and mechanism of action of titanocene dichloride.
    Christodoulou CV; Eliopoulos AG; Young LS; Hodgkins L; Ferry DR; Kerr DJ
    Br J Cancer; 1998 Jun; 77(12):2088-97. PubMed ID: 9649119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. XIAP associated factor 1 (XAF1) represses expression of X-linked inhibitor of apoptosis protein (XIAP) and regulates invasion, cell cycle, apoptosis, and cisplatin sensitivity of ovarian carcinoma cells.
    Zhao WJ; Deng BY; Wang XM; Miao Y; Wang JN
    Asian Pac J Cancer Prev; 2015; 16(6):2453-8. PubMed ID: 25824780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis.
    Peng B; Chang Q; Wang L; Hu Q; Wang Y; Tang J; Liu X
    Gynecol Oncol; 2008 Jan; 108(1):173-81. PubMed ID: 17959232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Platinum-based Compound with Preferential Cytotoxic Activity against a Panel of Cancer Cell Lines.
    Shahsavar F; Bozorgmehr M; Mirzadegan E; Abedi A; Lighvan ZM; Mohammadi F; Safari N; Amani V; Zarnani AH
    Anticancer Agents Med Chem; 2016; 16(3):393-403. PubMed ID: 26899296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells.
    Singh RK; Lange TS; Kim KK; Singh AP; Vorsa N; Brard L
    Br J Cancer; 2008 Dec; 99(11):1823-31. PubMed ID: 19002174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental therapy of ovarian cancer with synthetic makaluvamine analog: in vitro and in vivo anticancer activity and molecular mechanisms of action.
    Chen T; Xu Y; Guo H; Liu Y; Hu P; Yang X; Li X; Ge S; Velu SE; Nadkarni DH; Wang W; Zhang R; Wang H
    PLoS One; 2011; 6(6):e20729. PubMed ID: 21673964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
    Li X; Zhou Y; Liu Y; Zhang X; Chen T; Chen K; Ba Q; Li J; Liu H; Wang H
    EBioMedicine; 2016 Dec; 14():44-54. PubMed ID: 27939426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.